| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B DCHS2 VSNL1 CAPN1 CAPSL RCVRN PCDHAC1 PKD2L1 OCM2 RYR1 CAPN8 PPP2R3A HEG1 OCM FSTL1 C1S UNC13C PCDH10 PCDH9 HPCAL4 | 1.20e-06 | 749 | 153 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBA3D TUBA1C RAB11A RAB3D TUBA3E GIMAP7 TUBA8 TUBA3C TUBA1B ADSS2 TUBA1A PRKG1 RAB3A RAB3B ADSS1 | 1.49e-06 | 439 | 153 | 15 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBA3D TUBA1C RAB11A RAB3D TUBA3E GIMAP7 TUBA8 TUBA3C TUBA1B ADSS2 TUBA1A PRKG1 RAB3A RAB3B ADSS1 | 1.49e-06 | 439 | 153 | 15 | GO:0019001 |
| GeneOntologyMolecularFunction | GTP binding | TUBA3D TUBA1C RAB11A RAB3D TUBA3E GIMAP7 TUBA8 TUBA3C TUBA1B ADSS2 TUBA1A RAB3A RAB3B ADSS1 | 2.35e-06 | 397 | 153 | 14 | GO:0005525 |
| GeneOntologyMolecularFunction | myosin V binding | 1.46e-05 | 20 | 153 | 4 | GO:0031489 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 3.13e-05 | 24 | 153 | 4 | GO:0030742 | |
| GeneOntologyMolecularFunction | adenylosuccinate synthase activity | 5.83e-05 | 2 | 153 | 2 | GO:0004019 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 5.83e-05 | 2 | 153 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 5.83e-05 | 2 | 153 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.50e-05 | 130 | 153 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 DYNC2H1 RAB11A COQ8B RAB3D GIMAP7 RGS21 RGS1 TUBA1B MLH3 RGS18 SHOC1 DHX35 RAB3A RAB3B SMC1B ADSS1 | 9.59e-05 | 775 | 153 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 1.19e-04 | 13 | 153 | 3 | GO:0004535 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.61e-04 | 36 | 153 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 DYNC2H1 RAB11A COQ8B RAB3D GIMAP7 RGS21 RGS1 TUBA1B MLH3 RGS18 SHOC1 DHX35 RAB3A RAB3B SMC1B ADSS1 | 2.46e-04 | 839 | 153 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 DYNC2H1 RAB11A COQ8B RAB3D GIMAP7 RGS21 RGS1 TUBA1B MLH3 RGS18 SHOC1 DHX35 RAB3A RAB3B SMC1B ADSS1 | 2.50e-04 | 840 | 153 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 DYNC2H1 RAB11A COQ8B RAB3D GIMAP7 RGS21 RGS1 TUBA1B MLH3 RGS18 SHOC1 DHX35 RAB3A RAB3B SMC1B ADSS1 | 2.50e-04 | 840 | 153 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.77e-04 | 17 | 153 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | GTPase activity | RAB11A RAB3D GIMAP7 RGS21 RGS1 TUBA1B RGS18 RAB3A RAB3B ADSS1 | 3.07e-04 | 341 | 153 | 10 | GO:0003924 |
| GeneOntologyMolecularFunction | purine-rich negative regulatory element binding | 3.46e-04 | 4 | 153 | 2 | GO:0032422 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.57e-04 | 20 | 153 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.26e-03 | 28 | 153 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.87e-03 | 227 | 153 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.03e-03 | 9 | 153 | 2 | GO:0070016 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.39e-05 | 20 | 156 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 3.45e-05 | 9 | 156 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.45e-05 | 9 | 156 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.90e-05 | 10 | 156 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 4.90e-05 | 10 | 156 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | mammary gland involution | 6.70e-05 | 11 | 156 | 3 | GO:0060056 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 8.88e-05 | 12 | 156 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.15e-04 | 13 | 156 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.45e-04 | 14 | 156 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic dense core granule exocytosis | 1.70e-04 | 3 | 156 | 2 | GO:0099161 | |
| GeneOntologyBiologicalProcess | peptidyl-cysteine methylation | 1.70e-04 | 3 | 156 | 2 | GO:0018125 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 1.81e-04 | 15 | 156 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 2.21e-04 | 16 | 156 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 2.67e-04 | 17 | 156 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 2.67e-04 | 17 | 156 | 3 | GO:0002476 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.22e-05 | 8 | 156 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.71e-05 | 10 | 156 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.40e-04 | 14 | 156 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | stereocilium | 1.66e-04 | 69 | 156 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | microtubule | GAS2L3 DYNC2H1 TUBA3D TUBA1C RAB11A RAB3D TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A DNAH17 MID1 | 1.87e-04 | 533 | 156 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.96e-04 | 112 | 156 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.06e-04 | 18 | 156 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | stereocilium bundle | 3.14e-04 | 79 | 156 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | cytoplasmic region | UNC13B CENPF DYNC2H1 GRIK2 ARMCX3 TUBA1A PURA DNAH17 UNC13C HYDIN | 3.84e-04 | 360 | 156 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.23e-04 | 20 | 156 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.91e-04 | 21 | 156 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 6.02e-04 | 91 | 156 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | supramolecular fiber | GAS2L3 DYNC2H1 TUBA3D TUBA1C RAB11A RAB3D TUBA3E OCM2 TUBA8 TUBA3C RYR1 DNAJA3 TUBA1B MFAP4 OCM TUBA1A SCN1A DNAH17 MID1 | 1.28e-03 | 1179 | 156 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | GAS2L3 DYNC2H1 TUBA3D TUBA1C RAB11A RAB3D TUBA3E OCM2 TUBA8 TUBA3C RYR1 DNAJA3 TUBA1B MFAP4 OCM TUBA1A SCN1A DNAH17 MID1 | 1.39e-03 | 1187 | 156 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | glycogen granule | 1.50e-03 | 8 | 156 | 2 | GO:0042587 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.68e-06 | 16 | 120 | 4 | MP:0003701 | |
| Domain | Alpha_tubulin | 2.08e-11 | 9 | 151 | 6 | IPR002452 | |
| Domain | Tubulin_C | 1.69e-08 | 22 | 151 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.69e-08 | 22 | 151 | 6 | IPR018316 | |
| Domain | Tubulin_C | 1.69e-08 | 22 | 151 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 2.28e-08 | 23 | 151 | 6 | IPR008280 | |
| Domain | Tubulin_C | 2.28e-08 | 23 | 151 | 6 | IPR023123 | |
| Domain | TUBULIN | 2.28e-08 | 23 | 151 | 6 | PS00227 | |
| Domain | Tubulin | 2.28e-08 | 23 | 151 | 6 | IPR000217 | |
| Domain | Tubulin | 2.28e-08 | 23 | 151 | 6 | SM00864 | |
| Domain | Tubulin_CS | 2.28e-08 | 23 | 151 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 3.02e-08 | 24 | 151 | 6 | IPR003008 | |
| Domain | Tubulin | 3.02e-08 | 24 | 151 | 6 | PF00091 | |
| Domain | EF-hand-dom_pair | SYNRG VSNL1 CAPN1 CAPSL RCVRN PKD2L1 OCM2 RYR1 CAPN8 PPP2R3A OCM FSTL1 SCN1A HPCAL4 | 8.97e-08 | 287 | 151 | 14 | IPR011992 |
| Domain | - | SYNRG VSNL1 CAPN1 CAPSL RCVRN PKD2L1 OCM2 RYR1 CAPN8 PPP2R3A OCM FSTL1 HPCAL4 | 2.08e-07 | 261 | 151 | 13 | 1.10.238.10 |
| Domain | EF_hand_dom | VSNL1 CAPN1 CAPSL RCVRN PKD2L1 OCM2 RYR1 CAPN8 PPP2R3A OCM FSTL1 HPCAL4 | 4.16e-07 | 232 | 151 | 12 | IPR002048 |
| Domain | - | 4.54e-07 | 20 | 151 | 5 | 3.30.1330.20 | |
| Domain | - | 5.93e-07 | 21 | 151 | 5 | 1.10.287.600 | |
| Domain | - | 7.62e-07 | 22 | 151 | 5 | 3.40.50.1440 | |
| Domain | Grip | 1.30e-06 | 11 | 151 | 4 | SM00755 | |
| Domain | GRIP | 1.30e-06 | 11 | 151 | 4 | PF01465 | |
| Domain | Ran_BP1 | 1.93e-06 | 12 | 151 | 4 | PF00638 | |
| Domain | RANBD1 | 1.93e-06 | 12 | 151 | 4 | PS50196 | |
| Domain | GRIP_dom | 1.93e-06 | 12 | 151 | 4 | IPR000237 | |
| Domain | GRIP | 1.93e-06 | 12 | 151 | 4 | PS50913 | |
| Domain | RanBD | 2.77e-06 | 13 | 151 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 2.77e-06 | 13 | 151 | 4 | IPR000156 | |
| Domain | EFh | 5.60e-06 | 158 | 151 | 9 | SM00054 | |
| Domain | EF-hand_7 | 5.72e-06 | 85 | 151 | 7 | PF13499 | |
| Domain | EF_HAND_1 | VSNL1 CAPN1 CAPSL RCVRN PKD2L1 OCM2 CAPN8 PPP2R3A OCM HPCAL4 | 6.38e-06 | 204 | 151 | 10 | PS00018 |
| Domain | EF_Hand_1_Ca_BS | 1.28e-05 | 175 | 151 | 9 | IPR018247 | |
| Domain | Rab_bind | 1.77e-05 | 7 | 151 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.77e-05 | 7 | 151 | 3 | IPR032023 | |
| Domain | EF_HAND_2 | 1.89e-05 | 231 | 151 | 10 | PS50222 | |
| Domain | EF-hand_1 | 3.33e-05 | 152 | 151 | 8 | PF00036 | |
| Domain | - | 5.96e-05 | 10 | 151 | 3 | 1.10.220.60 | |
| Domain | Adenylsucc_synt | 6.49e-05 | 2 | 151 | 2 | SM00788 | |
| Domain | ADENYLOSUCCIN_SYN_2 | 6.49e-05 | 2 | 151 | 2 | PS00513 | |
| Domain | Adenylosuccin_syn_GTP-bd | 6.49e-05 | 2 | 151 | 2 | IPR018220 | |
| Domain | Adenylsucc_synt | 6.49e-05 | 2 | 151 | 2 | PF00709 | |
| Domain | Adenylosuccin_syn_Lys_AS | 6.49e-05 | 2 | 151 | 2 | IPR033128 | |
| Domain | Adenylosuccinate_synthetase | 6.49e-05 | 2 | 151 | 2 | IPR001114 | |
| Domain | ADENYLOSUCCIN_SYN_1 | 6.49e-05 | 2 | 151 | 2 | PS01266 | |
| Domain | PurA | 1.94e-04 | 3 | 151 | 2 | PF04845 | |
| Domain | PUR | 1.94e-04 | 3 | 151 | 2 | SM00712 | |
| Domain | Unc-13 | 1.94e-04 | 3 | 151 | 2 | IPR027080 | |
| Domain | PUR-bd_fam | 1.94e-04 | 3 | 151 | 2 | IPR006628 | |
| Domain | MHC_I | 6.19e-04 | 21 | 151 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 6.19e-04 | 21 | 151 | 3 | IPR001039 | |
| Domain | Munc13_dom-2 | 6.39e-04 | 5 | 151 | 2 | IPR014772 | |
| Domain | Parvalbumin | 6.39e-04 | 5 | 151 | 2 | IPR008080 | |
| Domain | MHD2 | 6.39e-04 | 5 | 151 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 6.39e-04 | 5 | 151 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 6.39e-04 | 5 | 151 | 2 | PF10540 | |
| Domain | DUF1041 | 6.39e-04 | 5 | 151 | 2 | SM01145 | |
| Domain | - | 7.13e-04 | 22 | 151 | 3 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 7.13e-04 | 22 | 151 | 3 | IPR024066 | |
| Domain | - | 9.26e-04 | 24 | 151 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 9.26e-04 | 24 | 151 | 3 | IPR011161 | |
| Domain | Munc13_1 | 1.33e-03 | 7 | 151 | 2 | IPR014770 | |
| Domain | MHD1 | 1.33e-03 | 7 | 151 | 2 | PS51258 | |
| Domain | DUF1041 | 1.33e-03 | 7 | 151 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.33e-03 | 7 | 151 | 2 | IPR010439 | |
| Domain | MYTH4 | 2.25e-03 | 9 | 151 | 2 | PS51016 | |
| Domain | MyTH4 | 2.25e-03 | 9 | 151 | 2 | SM00139 | |
| Domain | MyTH4_dom | 2.25e-03 | 9 | 151 | 2 | IPR000857 | |
| Domain | MyTH4 | 2.25e-03 | 9 | 151 | 2 | PF00784 | |
| Domain | EF-hand_8 | 2.58e-03 | 34 | 151 | 3 | PF13833 | |
| Domain | RGS | 2.80e-03 | 35 | 151 | 3 | PF00615 | |
| Domain | RGS | 2.80e-03 | 35 | 151 | 3 | SM00315 | |
| Domain | RAB | 2.90e-03 | 73 | 151 | 4 | PS51419 | |
| Domain | RGS | 3.04e-03 | 36 | 151 | 3 | PS50132 | |
| Domain | ARM-rpt_dom | 3.40e-03 | 11 | 151 | 2 | IPR006911 | |
| Domain | Arm_2 | 3.40e-03 | 11 | 151 | 2 | PF04826 | |
| Domain | MHC_I/II-like_Ag-recog | 3.55e-03 | 38 | 151 | 3 | IPR011162 | |
| Domain | RGS | 3.83e-03 | 39 | 151 | 3 | IPR016137 | |
| Domain | calpain_III | 4.06e-03 | 12 | 151 | 2 | SM00720 | |
| Domain | C2_III | 4.06e-03 | 12 | 151 | 2 | IPR033883 | |
| Domain | Calpain_III | 4.06e-03 | 12 | 151 | 2 | IPR022683 | |
| Domain | Calpain_III | 4.78e-03 | 13 | 151 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 4.78e-03 | 13 | 151 | 2 | IPR022682 | |
| Domain | Recoverin | 4.78e-03 | 13 | 151 | 2 | IPR028846 | |
| Domain | Calpain_cysteine_protease | 5.54e-03 | 14 | 151 | 2 | IPR022684 | |
| Domain | Peptidase_C2 | 6.36e-03 | 15 | 151 | 2 | PF00648 | |
| Domain | CysPc | 6.36e-03 | 15 | 151 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 6.36e-03 | 15 | 151 | 2 | IPR001300 | |
| Domain | CALPAIN_CAT | 6.36e-03 | 15 | 151 | 2 | PS50203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.54e-12 | 20 | 113 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.77e-12 | 24 | 113 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.21e-11 | 17 | 113 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.21e-11 | 18 | 113 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.20e-11 | 19 | 113 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.20e-11 | 19 | 113 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.25e-10 | 20 | 113 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.87e-10 | 21 | 113 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.87e-10 | 21 | 113 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.72e-10 | 22 | 113 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.89e-10 | 23 | 113 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.89e-10 | 23 | 113 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.89e-10 | 23 | 113 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 5.45e-10 | 24 | 113 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.52e-10 | 25 | 113 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.52e-10 | 25 | 113 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.02e-09 | 26 | 113 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.02e-09 | 26 | 113 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.52e-09 | 43 | 113 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.52e-09 | 43 | 113 | 8 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.82e-09 | 28 | 113 | 7 | M47898 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.23e-09 | 45 | 113 | 8 | M47670 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.38e-09 | 29 | 113 | 7 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.03e-09 | 32 | 113 | 7 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.03e-09 | 32 | 113 | 7 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 6.34e-09 | 33 | 113 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 6.34e-09 | 33 | 113 | 7 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 9.85e-09 | 35 | 113 | 7 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.81e-08 | 38 | 113 | 7 | M14981 | |
| Pathway | REACTOME_AGGREPHAGY | 5.29e-08 | 44 | 113 | 7 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 5.29e-08 | 44 | 113 | 7 | M27934 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.29e-08 | 46 | 113 | 7 | M27828 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.04e-07 | 72 | 113 | 8 | M26954 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.15e-07 | 49 | 113 | 7 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.53e-07 | 51 | 113 | 7 | M26972 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.59e-07 | 76 | 113 | 8 | M48037 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.73e-07 | 17 | 113 | 5 | MM14731 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.01e-07 | 53 | 113 | 7 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.61e-07 | 55 | 113 | 7 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.96e-07 | 56 | 113 | 7 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.35e-07 | 57 | 113 | 7 | M27251 | |
| Pathway | REACTOME_KINESINS | 5.38e-07 | 61 | 113 | 7 | M977 | |
| Pathway | KEGG_GAP_JUNCTION | 5.96e-07 | 90 | 113 | 8 | M4013 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 9.10e-07 | 129 | 113 | 9 | MM14894 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.54e-06 | 71 | 113 | 7 | M39690 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | UNC13B GLS2 ACHE TUBA3D TUBA1C TUBA3E GRIK2 TUBA8 TUBA3C TUBA1B TUBA1A RAB3A | 1.69e-06 | 270 | 113 | 12 | M15514 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.92e-06 | 141 | 113 | 9 | MM15266 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.12e-06 | 27 | 113 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.12e-06 | 27 | 113 | 5 | MM15674 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.44e-06 | 76 | 113 | 7 | M27215 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.08e-06 | 29 | 113 | 5 | MM15219 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.18e-06 | 79 | 113 | 7 | M27743 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.38e-06 | 54 | 113 | 6 | M27482 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | DYNC2H1 TUBA3D TUBA1C RAB11A TUBA3E TUBA8 TUBA3C TUBA1B TTBK2 TUBA1A | 4.82e-06 | 201 | 113 | 10 | M27472 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | RGPD2 RGPD8 CENPF TUBA3D TUBA1C RGPD1 TUBA8 TUBA1B TUBA1A NCAPD2 | 5.03e-06 | 202 | 113 | 10 | MM15362 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.13e-06 | 32 | 113 | 5 | MM14730 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 5.63e-06 | 121 | 113 | 8 | M872 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 7.62e-06 | 90 | 113 | 7 | M29841 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.06e-06 | 127 | 113 | 8 | M27181 | |
| Pathway | REACTOME_AGGREPHAGY | 9.36e-06 | 36 | 113 | 5 | MM15669 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.02e-05 | 94 | 113 | 7 | M2843 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.08e-05 | 37 | 113 | 5 | MM15102 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.09e-05 | 95 | 113 | 7 | M6729 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.34e-05 | 98 | 113 | 7 | M776 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.43e-05 | 66 | 113 | 6 | MM17074 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.48e-05 | 138 | 113 | 8 | M29805 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.53e-05 | 100 | 113 | 7 | M27650 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.65e-05 | 140 | 113 | 8 | M27550 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.72e-05 | 20 | 113 | 4 | MM1383 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.74e-05 | 102 | 113 | 7 | M27648 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.46e-05 | 193 | 113 | 9 | MM14890 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.56e-05 | 44 | 113 | 5 | MM14606 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.85e-05 | 151 | 113 | 8 | M550 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | CENPF TUBA3D TUBA1C TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A NCAPD2 | 3.80e-05 | 204 | 113 | 9 | M4217 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.94e-05 | 48 | 113 | 5 | MM15353 | |
| Pathway | REACTOME_AUTOPHAGY | 3.94e-05 | 158 | 113 | 8 | M27935 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3D TUBA1C CAPN1 ATG2B TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A EIF2AK2 | 4.64e-05 | 261 | 113 | 10 | M42565 |
| Pathway | REACTOME_HCMV_INFECTION | 4.71e-05 | 162 | 113 | 8 | M29804 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.83e-05 | 52 | 113 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.83e-05 | 52 | 113 | 5 | MM15211 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 6.63e-05 | 170 | 113 | 8 | M941 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3D TUBA1C TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A MID1 EIF2AK2 PML | 6.76e-05 | 273 | 113 | 10 | M983 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 6.79e-05 | 126 | 113 | 7 | M705 | |
| Pathway | REACTOME_KINESINS | 9.10e-05 | 57 | 113 | 5 | MM15714 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.00e-04 | 134 | 113 | 7 | M27751 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.07e-04 | 94 | 113 | 6 | MM14515 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.10e-04 | 234 | 113 | 9 | MM14898 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | UNC13B GLS2 ACHE TUBA3D TUBA1C TUBA3E GRIK2 TUBA8 TUBA3C TUBA1B TUBA1A RAB3A | 1.11e-04 | 411 | 113 | 12 | M735 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | DYNC2H1 TUBA3D TUBA1C RAB11A TUBA3E TUBA8 TUBA3C TUBA1B TTBK2 TUBA1A | 1.36e-04 | 297 | 113 | 10 | M27050 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.49e-04 | 191 | 113 | 8 | M29614 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 2.05e-04 | 200 | 113 | 8 | M864 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.11e-04 | 68 | 113 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.11e-04 | 68 | 113 | 5 | MM14968 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.22e-04 | 257 | 113 | 9 | MM14755 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.42e-04 | 205 | 113 | 8 | M752 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.57e-04 | 156 | 113 | 7 | M27097 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | TUBA3D TUBA1C CAPN1 ATG2B TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A EIF2AK2 | 2.88e-04 | 326 | 113 | 10 | M39379 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.92e-04 | 113 | 113 | 6 | M27471 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.95e-04 | 73 | 113 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.95e-04 | 73 | 113 | 5 | MM15672 | |
| Pubmed | 1.19e-15 | 9 | 157 | 7 | 21167302 | ||
| Pubmed | 1.61e-12 | 19 | 157 | 7 | 15698476 | ||
| Pubmed | 1.61e-12 | 19 | 157 | 7 | 15691386 | ||
| Pubmed | 5.38e-12 | 22 | 157 | 7 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 9.74e-11 | 8 | 157 | 5 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 5.40e-10 | 22 | 157 | 6 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.36e-09 | 12 | 157 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 2.20e-09 | 13 | 157 | 5 | 10908577 | |
| Pubmed | 3.41e-09 | 14 | 157 | 5 | 12486001 | ||
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 5.95e-09 | 6 | 157 | 4 | 7651436 | |
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 16327313 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.38e-08 | 7 | 157 | 4 | 15710750 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 11146551 | ||
| Pubmed | 4.35e-08 | 22 | 157 | 5 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 4.95e-08 | 9 | 157 | 4 | 11953448 | |
| Pubmed | 2.46e-07 | 94 | 157 | 7 | 36584595 | ||
| Pubmed | Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. | 3.60e-07 | 4 | 157 | 3 | 20716109 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 12167638 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 15269275 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 18400243 | ||
| Pubmed | Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. | 3.60e-07 | 4 | 157 | 3 | 16436611 | |
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 3.84e-07 | 62 | 157 | 6 | 17975119 | |
| Pubmed | Identification and characterization of multiple novel Rab-myosin Va interactions. | 3.86e-07 | 14 | 157 | 4 | 24006491 | |
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 4.22e-07 | 63 | 157 | 6 | 19023099 | |
| Pubmed | Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. | 8.97e-07 | 5 | 157 | 3 | 21262767 | |
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 8.97e-07 | 5 | 157 | 3 | 24572784 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 11598194 | ||
| Pubmed | Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. | 8.97e-07 | 5 | 157 | 3 | 15159548 | |
| Pubmed | 9.09e-07 | 17 | 157 | 4 | 17360745 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 12090300 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 20219610 | ||
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 1.79e-06 | 6 | 157 | 3 | 31679900 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 10840040 | ||
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 1.79e-06 | 6 | 157 | 3 | 19688209 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 12192047 | ||
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 3.12e-06 | 7 | 157 | 3 | 16831899 | |
| Pubmed | Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | 3.12e-06 | 7 | 157 | 3 | 35871249 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.12e-06 | 7 | 157 | 3 | 11353387 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 30944974 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.12e-06 | 7 | 157 | 3 | 7559465 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 25583577 | ||
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.12e-06 | 7 | 157 | 3 | 17372272 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 28559451 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 38657106 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 21205196 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 20870941 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 3.12e-06 | 7 | 157 | 3 | 30787931 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 18949001 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 25187515 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 36681692 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 12370332 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 8603673 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 26632511 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 24403063 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 23818861 | ||
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 3.12e-06 | 7 | 157 | 3 | 33542309 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 23536549 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 12191015 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 22821000 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.97e-06 | 8 | 157 | 3 | 21670213 | |
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 4.97e-06 | 8 | 157 | 3 | 12645935 | |
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.97e-06 | 8 | 157 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.97e-06 | 8 | 157 | 3 | 22262462 | |
| Pubmed | Rab11 endosomes contribute to mitotic spindle organization and orientation. | 4.97e-06 | 8 | 157 | 3 | 24561039 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.97e-06 | 8 | 157 | 3 | 28745977 | |
| Pubmed | 5.86e-06 | 212 | 157 | 8 | 23463506 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 7.43e-06 | 9 | 157 | 3 | 18394993 | |
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 28100513 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 17887960 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 11553612 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 10601307 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 9733766 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 28877029 | ||
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 7.43e-06 | 9 | 157 | 3 | 23136011 | |
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 19103752 | ||
| Pubmed | 1.06e-05 | 10 | 157 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.06e-05 | 10 | 157 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.06e-05 | 10 | 157 | 3 | 8857542 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 1.06e-05 | 10 | 157 | 3 | 11827464 | |
| Pubmed | 1.06e-05 | 10 | 157 | 3 | 21859863 | ||
| Pubmed | 1.30e-05 | 32 | 157 | 4 | 23049088 | ||
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.45e-05 | 11 | 157 | 3 | 35771867 | |
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 34110283 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DYNC2H1 TUBA3D TUBA1C CAPN1 RAB11A RYR1 TFRC FASN ADSS2 DLD MYO15A RAB3A CNOT1 HYDIN | 1.92e-05 | 807 | 157 | 14 | 30575818 |
| Pubmed | Structure and chromosomal localization of the mouse oncomodulin gene. | 2.02e-05 | 2 | 157 | 2 | 8597631 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 14516679 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 2474657 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 17322896 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 1448097 | ||
| Pubmed | Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses. | 2.02e-05 | 2 | 157 | 2 | 22674279 | |
| Pubmed | Disulfide-linked dimer of oncomodulin: comparison to calmodulin. | 2.02e-05 | 2 | 157 | 2 | 3179268 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19996387 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25328666 | ||
| Interaction | TCP11L2 interactions | 1.41e-10 | 21 | 154 | 7 | int:TCP11L2 | |
| Interaction | CAPSL interactions | 4.19e-06 | 15 | 154 | 4 | int:CAPSL | |
| Interaction | GRM7 interactions | 1.16e-05 | 19 | 154 | 4 | int:GRM7 | |
| Interaction | VRTN interactions | 1.77e-05 | 21 | 154 | 4 | int:VRTN | |
| Interaction | RGPD4 interactions | 2.15e-05 | 22 | 154 | 4 | int:RGPD4 | |
| Interaction | BSG interactions | TUBA3D TUBA1C RAB11A TUBA3E TUBA8 VIRMA TUBA3C TFRC CDC45 DNAJA3 TUBA1B FASN TUBA1A NCAPD2 ZNF598 RAB3B | 2.76e-05 | 631 | 154 | 16 | int:BSG |
| Interaction | RGPD3 interactions | 2.89e-05 | 47 | 154 | 5 | int:RGPD3 | |
| Interaction | RIMS2 interactions | 5.02e-05 | 27 | 154 | 4 | int:RIMS2 | |
| Interaction | RGPD2 interactions | 5.02e-05 | 27 | 154 | 4 | int:RGPD2 | |
| Cytoband | 2q13 | 9.04e-05 | 68 | 157 | 4 | 2q13 | |
| Cytoband | 12q13.12 | 3.03e-04 | 38 | 157 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 1.84e-10 | 26 | 113 | 7 | 778 | |
| GeneFamily | EF-hand domain containing | 9.56e-06 | 219 | 113 | 9 | 863 | |
| GeneFamily | UNC13 homologs | 2.30e-04 | 4 | 113 | 2 | 836 | |
| GeneFamily | Regulators of G-protein signaling | 2.91e-04 | 21 | 113 | 3 | 720 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 7.30e-04 | 65 | 113 | 4 | 388 | |
| GeneFamily | Non-clustered protocadherins | 2.45e-03 | 12 | 113 | 2 | 21 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.85e-03 | 15 | 113 | 2 | 696 | |
| GeneFamily | C2 domain containing|Calpains | 3.85e-03 | 15 | 113 | 2 | 975 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.59e-03 | 181 | 113 | 5 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.88e-03 | 115 | 113 | 4 | 769 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.86e-08 | 192 | 157 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.72e-08 | 148 | 157 | 8 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.58e-07 | 180 | 157 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.05e-07 | 184 | 157 | 8 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 3.18e-07 | 185 | 157 | 8 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.31e-07 | 186 | 157 | 8 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.22e-07 | 192 | 157 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.39e-07 | 193 | 157 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.39e-07 | 193 | 157 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.39e-07 | 193 | 157 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-07 | 199 | 157 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 171 | 157 | 7 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.66e-06 | 172 | 157 | 7 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 175 | 157 | 7 | db6be3e9e339918418fcaf9001ea15207aa6c993 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 175 | 157 | 7 | 8acac10c9eedccebcf3a3fe31bfee35afa54579f | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 4.30e-06 | 185 | 157 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 186 | 157 | 7 | 32d30f08b20a0a28e38b37bd52ab26d1d43736ce | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 190 | 157 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 190 | 157 | 7 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.30e-06 | 191 | 157 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.30e-06 | 191 | 157 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.49e-06 | 192 | 157 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-06 | 193 | 157 | 7 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.87e-06 | 194 | 157 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 196 | 157 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-06 | 197 | 157 | 7 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.93e-06 | 199 | 157 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-06 | 199 | 157 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-06 | 199 | 157 | 7 | fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.93e-06 | 199 | 157 | 7 | a457964ed95ce8cfc9d276508efbf79a2d195fe4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.16e-06 | 200 | 157 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.16e-06 | 200 | 157 | 7 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.16e-06 | 200 | 157 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.16e-06 | 200 | 157 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.16e-06 | 200 | 157 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.16e-06 | 200 | 157 | 7 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.16e-06 | 200 | 157 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.16e-06 | 200 | 157 | 7 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.16e-06 | 200 | 157 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.16e-06 | 200 | 157 | 7 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.16e-06 | 200 | 157 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.48e-06 | 132 | 157 | 6 | 8d30b71776f5f6da55dc78e0c5cb27be460004e3 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-06 | 137 | 157 | 6 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-06 | 137 | 157 | 6 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 148 | 157 | 6 | d44f6c5fc8d1fce4046598030a48fa57ed520a6a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 152 | 157 | 6 | ee7855d76a49d07a032677a4dc83aa6116d50518 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 152 | 157 | 6 | 3a1414ba6a4972698c3262a00b124428835c35cb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 153 | 157 | 6 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 154 | 157 | 6 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 154 | 157 | 6 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 157 | 157 | 6 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 168 | 157 | 6 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 168 | 157 | 6 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 168 | 157 | 6 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-05 | 171 | 157 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-05 | 171 | 157 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-05 | 172 | 157 | 6 | dd9ba79e1542fe9fa2c319077d83dd3fc0158f46 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.35e-05 | 172 | 157 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.46e-05 | 173 | 157 | 6 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 173 | 157 | 6 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-05 | 173 | 157 | 6 | 4ec147479b359cce1975d57a50ee1437a0e1e663 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 173 | 157 | 6 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 3.58e-05 | 174 | 157 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 178 | 157 | 6 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-05 | 178 | 157 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-05 | 179 | 157 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 179 | 157 | 6 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 180 | 157 | 6 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-05 | 110 | 157 | 5 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 181 | 157 | 6 | dae0d106f0eee5dba538617f8ed724925ea35f17 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.46e-05 | 181 | 157 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | 41a7543c8b703441ff6ac2307faffe5f798b2c41 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | 81c394959414173016426961478f670cd822f8b3 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.60e-05 | 182 | 157 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-05 | 183 | 157 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.74e-05 | 183 | 157 | 6 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 183 | 157 | 6 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 183 | 157 | 6 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-05 | 183 | 157 | 6 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.88e-05 | 184 | 157 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.88e-05 | 184 | 157 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-05 | 184 | 157 | 6 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.88e-05 | 184 | 157 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-05 | 184 | 157 | 6 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-05 | 184 | 157 | 6 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 4.88e-05 | 184 | 157 | 6 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 157 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 157 | 6 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 157 | 6 | 74b787e225d83efcb84e79c23499febe1a106622 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.19e-05 | 186 | 157 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.19e-05 | 186 | 157 | 6 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.19e-05 | 186 | 157 | 6 | 35f32fc2761435356c8f54b5bb2f026b8c070efe | |
| Drug | Epothilone D | 1.08e-08 | 12 | 156 | 5 | DB01873 | |
| Drug | Epothilone B | 1.08e-08 | 12 | 156 | 5 | DB03010 | |
| Drug | AC1L2P05 | 4.31e-07 | 23 | 156 | 5 | CID000125688 | |
| Drug | Stylophorin | 4.65e-07 | 43 | 156 | 6 | CID000010147 | |
| Drug | NSC292222 | 1.01e-06 | 27 | 156 | 5 | CID000099957 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.26e-06 | 4 | 156 | 3 | DB07574 | |
| Drug | NSC332598 | 2.08e-06 | 31 | 156 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.08e-06 | 31 | 156 | 5 | CID000023678 | |
| Drug | 2-phenyl-4-quinolone | 3.36e-06 | 34 | 156 | 5 | CID000161091 | |
| Drug | laulimalide | 5.92e-06 | 38 | 156 | 5 | CID006918457 | |
| Drug | indanone | 8.70e-06 | 41 | 156 | 5 | CID000006735 | |
| Drug | bromocolchicine | 1.16e-05 | 21 | 156 | 4 | CID000161518 | |
| Drug | colchifoline | 1.16e-05 | 21 | 156 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 1.16e-05 | 21 | 156 | 4 | CID000164454 | |
| Drug | SRI-3072 | 1.16e-05 | 21 | 156 | 4 | CID000493469 | |
| Drug | ABT-751 | 1.24e-05 | 44 | 156 | 5 | CID003035714 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.41e-05 | 22 | 156 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 1.41e-05 | 22 | 156 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.41e-05 | 22 | 156 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 1.41e-05 | 22 | 156 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.41e-05 | 22 | 156 | 4 | CID000023759 | |
| Drug | NSC-339672 | 1.41e-05 | 22 | 156 | 4 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.70e-05 | 23 | 156 | 4 | CID000006858 | |
| Drug | 2,3,4-tabp | 1.70e-05 | 23 | 156 | 4 | CID000125548 | |
| Drug | NSC-373301 | 1.70e-05 | 23 | 156 | 4 | CID000341375 | |
| Drug | NSC355636 | 1.70e-05 | 23 | 156 | 4 | CID000100176 | |
| Drug | IKP104 | 1.70e-05 | 23 | 156 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.70e-05 | 23 | 156 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 1.70e-05 | 23 | 156 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.70e-05 | 23 | 156 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.70e-05 | 23 | 156 | 4 | CID000097865 | |
| Drug | parbendazole | 2.02e-05 | 24 | 156 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 2.02e-05 | 24 | 156 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 2.02e-05 | 24 | 156 | 4 | CID000330401 | |
| Drug | NABV | 2.02e-05 | 24 | 156 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 2.02e-05 | 24 | 156 | 4 | CID000163705 | |
| Drug | moscatilin | 2.02e-05 | 24 | 156 | 4 | CID000176096 | |
| Drug | NSC-36768 | 2.02e-05 | 24 | 156 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 2.02e-05 | 24 | 156 | 4 | CID000014995 | |
| Drug | colchicide | 2.02e-05 | 24 | 156 | 4 | CID000120712 | |
| Drug | GaCl3 | 2.34e-05 | 50 | 156 | 5 | CID000026010 | |
| Drug | mpMap | 2.40e-05 | 25 | 156 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 2.40e-05 | 25 | 156 | 4 | CID000160263 | |
| Drug | allocolchicine | 2.40e-05 | 25 | 156 | 4 | CID000196989 | |
| Drug | 1069C85 | 2.40e-05 | 25 | 156 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 2.40e-05 | 25 | 156 | 4 | CID006438440 | |
| Drug | MDL 27048 | 2.40e-05 | 25 | 156 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 2.40e-05 | 25 | 156 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.40e-05 | 25 | 156 | 4 | CID000043264 | |
| Drug | CA1P | 2.40e-05 | 25 | 156 | 4 | CID006918545 | |
| Drug | peloruside A | 2.40e-05 | 25 | 156 | 4 | CID006918506 | |
| Drug | NSC142227 | 2.40e-05 | 25 | 156 | 4 | CID000073427 | |
| Drug | NSC527981 | 2.82e-05 | 26 | 156 | 4 | CID000352796 | |
| Drug | NSC332029 | 2.82e-05 | 26 | 156 | 4 | CID000100073 | |
| Drug | indibulin | 2.82e-05 | 26 | 156 | 4 | CID000002929 | |
| Drug | pironetin | 2.82e-05 | 26 | 156 | 4 | CID006438891 | |
| Drug | isaxonine | 2.82e-05 | 26 | 156 | 4 | CID000071169 | |
| Drug | AC1L1J4H | 3.29e-05 | 27 | 156 | 4 | CID000004862 | |
| Drug | dinitroanilines | 3.29e-05 | 27 | 156 | 4 | CID000136400 | |
| Drug | NSC D-669356 | 3.29e-05 | 27 | 156 | 4 | CID000178028 | |
| Drug | NSC 370147 | 3.82e-05 | 28 | 156 | 4 | CID000182762 | |
| Drug | NSC72302 | 3.82e-05 | 28 | 156 | 4 | CID000118078 | |
| Drug | 2,5-hexanedione | 4.08e-05 | 56 | 156 | 5 | CID000008035 | |
| Drug | bp U | 4.41e-05 | 29 | 156 | 4 | CID000368697 | |
| Drug | oxibendazole | 4.41e-05 | 29 | 156 | 4 | CID000004622 | |
| Drug | Aids106696 | 4.41e-05 | 29 | 156 | 4 | CID006475933 | |
| Drug | ddGDP | 4.41e-05 | 29 | 156 | 4 | CID000134739 | |
| Drug | AC1LAPI9 | 4.66e-05 | 2 | 156 | 2 | CID000472615 | |
| Drug | AC1L1IZ2 | TUBA1C TUBA3E TUBA8 RYR1 ITPK1 TUBA1A IRAK4 PRKG1 MYO15A RAB3A | 4.89e-05 | 304 | 156 | 10 | CID000004795 |
| Drug | AC1NBBHE | 5.06e-05 | 30 | 156 | 4 | CID004490620 | |
| Drug | eleutherobin | 5.06e-05 | 30 | 156 | 4 | CID006918335 | |
| Drug | azatoxin | 5.06e-05 | 30 | 156 | 4 | CID000125383 | |
| Drug | NSC617668 | 5.06e-05 | 30 | 156 | 4 | CID000357989 | |
| Drug | citostal | 5.06e-05 | 30 | 156 | 4 | CID000018991 | |
| Drug | thiocolchicine | 5.06e-05 | 30 | 156 | 4 | CID000017648 | |
| Drug | NSC609395 | 5.78e-05 | 31 | 156 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 5.78e-05 | 31 | 156 | 4 | CID000100524 | |
| Drug | AC7700 | 5.78e-05 | 31 | 156 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 5.78e-05 | 31 | 156 | 4 | CID000032851 | |
| Drug | tropone | 5.78e-05 | 31 | 156 | 4 | CID000010881 | |
| Drug | AC1L3V8I | 5.78e-05 | 31 | 156 | 4 | CID000122777 | |
| Drug | AC1L1G95 | 6.57e-05 | 32 | 156 | 4 | CID000003583 | |
| Drug | NSC153858 | 6.57e-05 | 32 | 156 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 6.57e-05 | 32 | 156 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 6.57e-05 | 32 | 156 | 4 | CID000023757 | |
| Drug | mebendazole | 7.43e-05 | 33 | 156 | 4 | CID000004030 | |
| Drug | CA4P | 7.43e-05 | 33 | 156 | 4 | CID000370232 | |
| Drug | taltobulin | 7.43e-05 | 33 | 156 | 4 | CID006918637 | |
| Drug | triethyllead | 8.38e-05 | 34 | 156 | 4 | CID006328106 | |
| Drug | NSC376450 | 8.38e-05 | 34 | 156 | 4 | CID000005605 | |
| Drug | discodermolide | 9.41e-05 | 35 | 156 | 4 | CID000643668 | |
| Drug | dimethylarsinic acid | 9.60e-05 | 107 | 156 | 6 | CID000002513 | |
| Drug | AC1O5Y0F | 1.17e-04 | 37 | 156 | 4 | CID006442852 | |
| Drug | DTAF | 1.17e-04 | 37 | 156 | 4 | CID000123934 | |
| Drug | albendazole | 1.17e-04 | 37 | 156 | 4 | CID000002082 | |
| Drug | baccatin III | 1.17e-04 | 37 | 156 | 4 | CID000065366 | |
| Drug | gnoscopine | 1.31e-04 | 38 | 156 | 4 | CID000004544 | |
| Drug | colchiceine | 1.31e-04 | 38 | 156 | 4 | CID000010156 | |
| Drug | Ac-Gly | 1.35e-04 | 15 | 156 | 3 | CID000010972 | |
| Drug | pivalic anhydride | 1.39e-04 | 3 | 156 | 2 | CID000015234 | |
| Disease | microlissencephaly (implicated_via_orthology) | 7.32e-16 | 8 | 154 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 7.32e-16 | 8 | 154 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 7.32e-16 | 8 | 154 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 7.48e-11 | 27 | 154 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.02e-06 | 195 | 154 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.48e-05 | 163 | 154 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | level of UL16-binding protein 6 in blood serum | 2.71e-05 | 2 | 154 | 2 | OBA_2043185 | |
| Disease | regulator of G-protein signaling 18 measurement | 8.09e-05 | 3 | 154 | 2 | EFO_0801995 | |
| Disease | sarcoma (biomarker_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:1115 (biomarker_via_orthology) | |
| Disease | GRAM domain-containing protein 1C measurement | 8.09e-05 | 3 | 154 | 2 | EFO_0801652 | |
| Disease | multiple sclerosis symptom measurement | 9.82e-05 | 46 | 154 | 4 | EFO_0803536 | |
| Disease | serpin A9 measurement | 1.61e-04 | 4 | 154 | 2 | EFO_0802062 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | cadherin-3 measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0020213 | |
| Disease | diffuse large B-cell lymphoma, multiple sclerosis | 5.59e-04 | 7 | 154 | 2 | EFO_0000403, MONDO_0005301 | |
| Disease | hypertensive nephropathy | 5.59e-04 | 7 | 154 | 2 | MONDO_0024633 | |
| Disease | clusterin measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0007655 | |
| Disease | glutathione s-transferase p measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0020410 | |
| Disease | phosphatidylcholine measurement | 7.58e-04 | 284 | 154 | 7 | EFO_0010226 | |
| Disease | phospholipid measurement | 8.59e-04 | 140 | 154 | 5 | EFO_0004639 | |
| Disease | threonine measurement | 9.51e-04 | 37 | 154 | 3 | EFO_0009775 | |
| Disease | marginal zone B-cell lymphoma, multiple sclerosis | 9.51e-04 | 9 | 154 | 2 | EFO_1000630, MONDO_0005301 | |
| Disease | insomnia, total blood protein measurement | 1.10e-03 | 148 | 154 | 5 | EFO_0004536, EFO_0004698 | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0022012 | |
| Disease | Alopecia Areata | 1.18e-03 | 10 | 154 | 2 | C0002171 | |
| Disease | glaucoma | 1.31e-03 | 154 | 154 | 5 | MONDO_0005041 | |
| Disease | beta wave measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0006871 | |
| Disease | type 1 diabetes mellitus | 1.75e-03 | 242 | 154 | 6 | MONDO_0005147 | |
| Disease | selective IgA deficiency disease | 1.80e-03 | 46 | 154 | 3 | EFO_1001929 | |
| Disease | alcohol and nicotine codependence | 2.03e-03 | 13 | 154 | 2 | EFO_0004776 | |
| Disease | tyrosine measurement | 2.19e-03 | 104 | 154 | 4 | EFO_0005058 | |
| Disease | colonic neoplasm, overall survival | 2.36e-03 | 14 | 154 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | Schizophrenia | ABCA1 VSNL1 ACHE INPP5A GRIK2 NDUFV1 PNPO SLC26A8 FSTL1 ADSS2 PDE7B PML | 2.38e-03 | 883 | 154 | 12 | C0036341 |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.51e-03 | 108 | 154 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | generalised epilepsy | 2.55e-03 | 52 | 154 | 3 | EFO_0005917 | |
| Disease | fibrinogen measurement | 2.60e-03 | 109 | 154 | 4 | EFO_0004623 | |
| Disease | triacylglycerol 52:3 measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0010415 | |
| Disease | non-dense area measurement, mammographic density measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0005941, EFO_0006504 | |
| Disease | pathological myopia | 2.77e-03 | 111 | 154 | 4 | EFO_0004207 | |
| Disease | basal cell carcinoma | 3.20e-03 | 189 | 154 | 5 | EFO_0004193 | |
| Disease | keratinocyte carcinoma | 3.45e-03 | 118 | 154 | 4 | EFO_0010176 | |
| Disease | adult onset asthma | 3.45e-03 | 118 | 154 | 4 | EFO_1002011 | |
| Disease | FEV change measurement, response to bronchodilator | 3.49e-03 | 58 | 154 | 3 | EFO_0005921, GO_0097366 | |
| Disease | rhinitis | 3.50e-03 | 17 | 154 | 2 | EFO_0008521 | |
| Disease | C-X-C motif chemokine 16 measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0010911 | |
| Disease | coronary artery disease | ABCA1 GLS2 DYNC2H1 PPP1R9A PKD2L1 ITPK1 PPP2R3A IL1F10 RBFOX1 SHOC1 PAN2 C1S PRKG1 SEZ6L | 4.02e-03 | 1194 | 154 | 14 | EFO_0001645 |
| Disease | response to opioid | 4.02e-03 | 61 | 154 | 3 | EFO_0008541 | |
| Disease | cognitive decline measurement | 4.12e-03 | 486 | 154 | 8 | EFO_0007710 | |
| Disease | celiac disease | 4.36e-03 | 126 | 154 | 4 | EFO_0001060 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | docosahexaenoic acid measurement | 4.49e-03 | 127 | 154 | 4 | EFO_0007761 | |
| Disease | chronic kidney disease (is_marker_for) | 4.83e-03 | 20 | 154 | 2 | DOID:784 (is_marker_for) | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 4.83e-03 | 20 | 154 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | brain age measurement | 4.83e-03 | 20 | 154 | 2 | EFO_0010602 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFSKDNESLISRAEF | 376 | P22303 | |
| SEKFFFTSFGARDRS | 151 | Q8IYS0 | |
| FFEGRFESTIKSETN | 151 | H3BNL8 | |
| KDSSADRFLNSLGRF | 1566 | O95477 | |
| VFSDSQLSGLEKRFE | 116 | Q3C1V8 | |
| NEAFSKRTDIKFDGF | 561 | A6NHC0 | |
| EGDFVLRFFSEKSAG | 506 | P07384 | |
| SKFALDGFFSSIRKE | 186 | P28845 | |
| SNSAGNDVFAKFSAF | 566 | Q96NY7 | |
| SDFFRLFSAGNEETK | 246 | Q9UH62 | |
| STEDFKSFRAVFAEA | 556 | Q96BY7 | |
| KFTASFEASLSGERE | 156 | Q96DT6 | |
| EGFDFFFSLSNKVKD | 686 | Q8TE57 | |
| ESVGDKLRTSFLAFN | 411 | Q9NUZ1 | |
| TDEARAFAEKNGLSF | 136 | P62491 | |
| EFSSFDKNDSRGQEA | 231 | Q8IUH3 | |
| SSVGKTSFLFRYADD | 31 | P20336 | |
| SSVGKTSFLFRYADD | 31 | P20337 | |
| SSVGKTSFLFRYADD | 31 | O95716 | |
| FADVAKSTSGEGFQF | 971 | Q99666 | |
| FADVAKSTSGEGFQF | 971 | O14715 | |
| QNVFGSFLKSEFSEE | 96 | Q08116 | |
| SSIDFLASQGFDFNK | 111 | O95453 | |
| FDVSASKQALAFGDS | 336 | Q504Q3 | |
| TDGFEDIKARFFGSS | 916 | Q6ZVH7 | |
| KGGEEATRFTFFQSS | 91 | Q8WWZ1 | |
| KNFSAGTSDRESIFF | 216 | Q13572 | |
| TFDKNGDGTIDFREF | 71 | Q9UM19 | |
| LENSEFRAFSSFKNR | 66 | P19256 | |
| DNSSRFGKFVEIFLE | 1366 | Q9UKN7 | |
| NGTIKDDFSEFDNLR | 451 | O95208 | |
| EAEAAFFANLKLSDF | 346 | Q13976 | |
| RAFRKGTTDTFEFDS | 1851 | Q8IVV2 | |
| RKASFDQDFCFDGLS | 311 | A6NLJ0 | |
| GDFNFRLDSKSVVET | 231 | Q14642 | |
| SEDNGFSLFDATLQK | 366 | Q9UHC1 | |
| NASFFDLDRKTGVLT | 511 | Q9HC56 | |
| DFDIFLFDRLTNGNS | 116 | Q9NP56 | |
| SNGEFFFKSSELFES | 156 | Q9H0H0 | |
| QTSRSFASAAAFGDK | 456 | Q8IY47 | |
| FSNATFQSEKETGDR | 306 | Q9UI32 | |
| FFLQKFESGARELTE | 66 | P0CE71 | |
| SFDSLESGKQQDVRF | 46 | Q96GN5 | |
| EFDERIAAFQTKSGT | 216 | Q9ULI3 | |
| GFRFFTNFESRKGKE | 106 | Q9NVS9 | |
| AGTFFFADSSVQKED | 11 | A4D1T9 | |
| GEASLLEKETTRFFF | 1101 | Q76FK4 | |
| TRFFFFSKNDERLQG | 1111 | Q76FK4 | |
| LKDFSFQVEARDAGS | 536 | Q9P2E7 | |
| KFEEGDQRDFTNSSS | 491 | Q06190 | |
| AASKFALEGFFESLA | 156 | Q9NYR8 | |
| SFGENDIFRLKAFAT | 231 | Q86VF5 | |
| VFNAKDDDGSFLNSR | 1531 | Q6V1P9 | |
| AITAKTSFDFEQLRG | 506 | Q9H158 | |
| FFLQKFESGARELTE | 66 | P0CE72 | |
| KAESFNFSSSGREDV | 331 | Q3MIT2 | |
| VFIDNKGFFDRSEDN | 426 | Q6UWH4 | |
| RNASGFLTIFSKAED | 831 | Q8NCM8 | |
| FFGRAFEKAAESTSS | 521 | O75419 | |
| KEEQGFDFSFQDNSR | 4111 | Q4G0P3 | |
| GSEDFETRSSFQKRY | 191 | A2AJT9 | |
| RFDKDGNGTIDFNEF | 86 | Q8WWF8 | |
| IGKRDANSSFFDNSS | 261 | P49454 | |
| ESLFSENETFRKFVG | 701 | Q9UFH2 | |
| DTAFETSKFFTDLRD | 486 | P19525 | |
| KKDAASGSFFARDNT | 111 | Q86XJ1 | |
| VASATLDADKFRDFF | 206 | Q9H5Z1 | |
| FDNGDSRLDSSEFLK | 156 | Q12841 | |
| KLARDYSGFDSIQSF | 96 | P17707 | |
| KSDFSNEERFTGFAA | 111 | P09871 | |
| KATAADSLFDRQGFL | 591 | Q5VZ89 | |
| RDLKFLTGFETKAFS | 421 | Q96D53 | |
| SEAFREANLAASFGK | 491 | P09622 | |
| RFEGNKRVTDASFKF | 406 | Q8NEE6 | |
| RGKFDFSGNLDLEAF | 106 | Q8IW92 | |
| EAFTAKISDFGLARA | 321 | Q9NWZ3 | |
| FANAVSDALDSFKSG | 166 | Q6UWR7 | |
| TFNKTNGLRTDFDLD | 376 | Q13002 | |
| SGKLKDLSRFDASFF | 51 | P49327 | |
| ADFGLARAFSLAKNS | 166 | P50750 | |
| FRKIFGEFSSSSFGD | 186 | Q96EY1 | |
| NQSESSGEDFFLKSR | 561 | A0AV02 | |
| FEQSASLDIKSFFGF | 126 | Q92503 | |
| GTNFRFTRFVEDSKE | 1306 | Q9NSC2 | |
| LDSSSIEKRFAFGFL | 2946 | P21817 | |
| RKASFDQDFCFDGLS | 316 | Q8NCU7 | |
| TDAGDRSIKVFDFFG | 191 | Q6VVB1 | |
| EGTSITVDSKRFFFD | 221 | Q96QR8 | |
| DRDFNQFSSGEKNIF | 336 | P02771 | |
| DRLKVTFEDATDFFG | 111 | Q86WQ0 | |
| KDTYAGSDRDTFSFD | 181 | Q86XI6 | |
| DEKLRNEFSSFGSIS | 306 | P0CB38 | |
| FADVAKSTSGEGFQF | 956 | P0DJD0 | |
| FLEKLAFSSTARFDS | 111 | Q10713 | |
| GLDAFRIFLKSEFSE | 31 | Q2M5E4 | |
| KGFGFVTFENSADAD | 156 | Q9NWB1 | |
| STFFGTSDEFIEKRR | 86 | Q9Y5W9 | |
| LDNFKFLESAAADFS | 231 | O43815 | |
| AASTFNIRFEAFEKG | 551 | Q9BYH1 | |
| LSDFDEFSSRFKNLA | 186 | Q8N142 | |
| SFTAETSDDLSFKRG | 671 | Q5HYK7 | |
| FRSAGTDDGFTDFKT | 561 | Q9UMZ2 | |
| RKNIFRFDESTTGFN | 1271 | P0DJD1 | |
| RFDESTTGFNFSFKS | 1276 | P0DJD1 | |
| RSFDSNLDGTLDFKE | 71 | P35243 | |
| RNDFFDAGITKTQLF | 771 | Q96RN1 | |
| SFGSLKDEDRIFTNL | 31 | P49821 | |
| SLQAAVRTDGFDEFK | 366 | P29590 | |
| FTRKEELEGQSFHDF | 131 | Q8NHV1 | |
| SGQKFSTFDRDQDLF | 181 | P55083 | |
| FIRFGSFEIFKSADE | 251 | Q9BVL4 | |
| LDFKGQIFTEANFSR | 121 | Q5VXU9 | |
| SDFDGFSERFKVLAN | 186 | P30520 | |
| LAKASTDAEGRFFID | 66 | Q9BQ13 | |
| LTTDFGNAEKTDRFV | 656 | P02786 | |
| FDKNADFSGIAKRDS | 331 | Q86WD7 | |
| SFRGRAKDVGSENDF | 576 | P35498 | |
| EFSRSSLFFLFKESG | 411 | Q9P291 | |
| FEGFRESSAKSGQFS | 81 | Q96F83 | |
| NFDCFGDKLSDESIF | 1246 | Q15021 | |
| GDQNDSSVFDFFLEK | 61 | Q2KHT3 | |
| AAAGRDSTKAFSAFV | 1866 | A5YKK6 | |
| GDFDFTKSVSQRASV | 871 | Q9BXU1 | |
| SLFLVREKEDGAFSF | 161 | Q15036 | |
| QFSFDGRKFLLFDSN | 141 | Q9BZM4 | |
| DDSFNTFFSETGAGK | 46 | P0DPH8 | |
| EGSSFRKGFRLDTDD | 116 | Q96C28 | |
| TFDKNGDGTIDFREF | 71 | P62760 | |
| GLEAFTRFLKTEFSE | 96 | Q9NS28 | |
| SDRFAATNFGREKFI | 1466 | Q8NB66 | |
| RDKFQESTDAFEASR | 1031 | Q8NDV3 | |
| SFRVKENFDKARFSG | 26 | P02753 | |
| QKFQDSFAFLTAEDS | 586 | Q5T4T6 | |
| NDTFDTFALDFSREK | 356 | O15344 | |
| RQFKSFLGDLSSASD | 986 | Q6IQ55 | |
| DDSFNTFFSETGAGK | 46 | P0DPH7 | |
| SAGEEFFVLKSFFSA | 81 | O75830 | |
| ADVLKDFSLAGNFSR | 966 | O95359 | |
| VSASDRFAASNFGKE | 841 | O14795 | |
| FSIDGQTFLLFDSEK | 141 | Q5VY80 | |
| TELTATFTKFDRDGN | 636 | Q9P0L9 | |
| FDGTNDETERQRKFS | 261 | P57060 | |
| DFLQSDEARFSEFKS | 766 | Q86UK7 | |
| ATKFGETFAFENRLE | 6 | Q9UC06 | |
| DDSFNTFFSETGAGK | 46 | Q71U36 | |
| DDSFNTFFSETGAGK | 46 | Q6PEY2 | |
| FSFDGQIFLLFDSEK | 141 | Q9BZM5 | |
| DDSFNTFFSETGAGK | 46 | P68363 | |
| FSKDTGELASSFLEF | 1386 | Q69YN4 | |
| FDAFTDLKNGSLFAF | 161 | P04004 | |
| ETFNKEAFLASRGLT | 386 | Q9H091 | |
| GTSLTVDNKRFFFDV | 221 | Q00577 | |
| TSRKFEEGSFANSTD | 126 | Q702N8 | |
| DDSFNTFFSETGAGK | 46 | Q9BQE3 | |
| GFEAEFKRSQSSFNL | 81 | A0A0A6YYJ7 | |
| DDSFTTFFSETGNGK | 46 | Q9NY65 | |
| TDFFSFACGRAKETN | 101 | P23276 | |
| ISQKEGDFFFDSLRE | 1851 | Q6PIF6 | |
| DGEDSLERKNFTFND | 911 | Q9ULJ8 | |
| LERKNFTFNDDFSPS | 916 | Q9ULJ8 |